NCT02299466 Registry for Patients Receiving Intravenous Nutrition at Home
| NCT ID | NCT02299466 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Parenteral Nutrition, Home |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2005-12 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2005-12 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of study is to build a Canadian HTPN Registry to collect pertinent demographic and clinical data on the HTPN population in Canada and to determine the factors affecting survival, complications and TPN-dependency. These results will help establish standards of practice and develop future multi-center studies. This will greatly benefit the HTPN patient population.
Eligibility Criteria
Inclusion Criteria: * Patients with long-term administration of home total parenteral nutrition Age \>18 years Exclusion Criteria: * None
Contact & Investigator
Johane Allard, MD, FRCPC
PRINCIPAL INVESTIGATOR
University Health Network, Toronto
Frequently Asked Questions
Who can join the NCT02299466 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Parenteral Nutrition, Home. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02299466 currently recruiting?
Yes, NCT02299466 is actively recruiting participants. Contact the research team at johane.allard@uhn.on.ca for enrollment information.
Where is the NCT02299466 trial being conducted?
This trial is being conducted at Calgary, Canada, Edmonton, Canada, Vancouver, Canada, Winnipeg, Canada and 6 additional locations.
Who is sponsoring the NCT02299466 clinical trial?
NCT02299466 is sponsored by University Health Network, Toronto. The principal investigator is Johane Allard, MD, FRCPC at University Health Network, Toronto. The trial plans to enroll 1,000 participants.